Cannabis, marijuana and Hemp stock news from Investorideas.com plus daily cannabis #potcasts - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $KHRN.V) (NYSE: $ACB) (TSX: $ACB.TO) (TSXV: $BVO.V) (CSE: $MTEC.C) (OTCQB: $GBLX)
This month's cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa
Delta, Kelowna, BC - November 27, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Good afternoon, welcome to another Investorideas.com "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, announced today that the Company has received approval to commercialize and market four key products in the Company's Kuida® CBD cosmeceutical product line in Peru. This approval, from Peru's Executive Director of the Directorate of Medical Devices and Health Products of the General Directorate of Medications, Supplies and Drugs (DIGEMID) brings Kuida® product to a population of 32 Million people in Peru, and with previously announced agreements in Colombia and Mexico, positions the Kuida® brand to now be marketed to a combined population of almost 200 Million in Latin America.
Alvaro Torres, Co-founder and CEO for Khiron stated," Khiron is entirely focused on the Latin American cannabis market and meeting the needs of it's 620 million residents. With today's announcement to commercialize our Kuida® brand in Peru we expand our reach into an important new market. Peru is a region with a fast-growing cosmetic sector and an established legalized cannabis environment, which provides us with a strong foundation on which to build the Kuida® brand."
Aurora Cannabis Inc. announced today that the company has received an export request, has secured the required export permit and has now completed its first shipment of medical cannabis products to the Czech Republic, making this the 21st country in which the company operates.
The initial purchase order was placed by, and products will be shipped to Czech Medical Herbs s.r.o. ("CMH"), a Czech pharmaceutical wholesaler, who will subsequently supply pharmacies throughout the country. Czech Medical Herbs is a distributor of medicinal products with a specialization in Cannabis for medical use and medicinal products based on cannabinoids.
"This supply arrangement demonstrates our ability to enter into new jurisdictions as the partner of choice in new markets with strong barriers to entry, and is testament to the strength and business execution of our European business development team," said Neil Belot, Chief Global Business Development Officer. "The Czech Republic represents the 21st country in which we operate, and exemplifies how we are rapidly expanding our global footprint in the medical cannabis space. We look forward to building a long-term relationship with our customer, CMH, and supplying patients in the Czech Republic with our high-quality cannabis products."
Bevo Agro Inc. and Sun Pharm Investments Ltd. "Sun Pharm" announced that Zenabis has signed subscription agreements with three additional strategic investors, including two members of the ownership and management team of Hillsboro Corp Inc. ("True Buch"), for $2.1m at a subscription price of $5.00 per share for a total of 420,000 common shares. Sun Pharm agreed verbally to the price of $5.05 per share on November 16, 2018, after taking into account the exchange ratio of 0.991x. This represents a premium of $0.35 to the closing price of Bevo of $4.70 on that day. True Buch previously invested $1.0m at a subscription price of $2.82 per share for a total of 354,610 common shares, representing a total investment of $3.1m.
True Buch is a kombucha company with expertise in the creation of cultured tea beverages. True Buch cultured tea beverages are raw, unpasteurized, gluten free and non-GMO, with over 11 distinct flavours. Zenabis and TrueBuch intend to utilize each other's expertise to infuse cannabis into True Buch beverages, creating a cultured tea beverage CBD product.
"As previously announced on October 16, 2018, Zenabis and True Buch formed a significant partnership to develop and distribute CBD-based kombucha," said Rick Brar, CEO of Zenabis. "This commitment from large existing owners of True Buch shows their belief in our mission and our partnership. We believe our combined expertise in product and brand development and Kombucha brewing will result in delivery of a superior product to Canadians nationwide."
Cannvas MedTech Inc., a leading digital cannabis educator and business technology company, reported over one million cannabis consumer data points have been collected since the launch of its digital cannabis education platform. The Cannvas.Me education platform uses artificial intelligence to contextualize and adapt to its users as they navigate its education platform, ensuring a best-in-class experience while collecting valuable industry and customer data points. Cannvas Data (Cannvas MedTechs Advanced Analytics division) uses the same advanced technology to closely analyze and process data points to reveal highly focused and relevant cannabis industry insights.
"What sets us apart is our ability to truly understand the power of cannabis data due to extensive backgrounds of using data as a framework for CRM and pharma programs," said Shawn Moniz, Chief Executive Officer, Cannvas MedTech Inc. "Our team has decades of experience building these platforms in the CPG, financial and pharma industries, and we are proud to report a fantastic response to the launch of Cannvas.Me. It is clear that cannabis consumers value our independence and our unbiased physician-backed content, and with each visit we gain important consumer data that contributes to the Cannvas database. We look forward to the continued rapid growth in website traffic as we add new and dynamic education modules and sign value-added partnerships with leading cannabis companies."
GB Sciences, Inc. announced the publication of a research article co-authored by GB Sciences and key collaborators in the peer-reviewed journal Channels, which explains the potential medical benefits of using cannabinoid receptor-targeting therapies for the treatment of heart disease. GB Sciences' own Chief Science Officer, Dr. Andrea Small-Howard, joins co-authors including University of Hawaii faculty member and President of Makai Biotechnology, LLC, Dr. Alexander Stokes, and researchers from the University of Kyoto, Japan.
The link to the article as published in PubMed, the notable government source for medical studies, is found at https://www.ncbi.nlm.nih.gov/pubmed/30424709.
"People are becoming more aware that cannabinoid-based therapies can have significant medical benefits for patients, and this research study brings attention to the potential life-saving applications of cannabinoids for the treatment of heart conditions through the manipulation of specific-cannabinoid sensitive receptors," explains Dr. Andrea Small-Howard. "Our study highlights the involvement of the cannabinoid-sensitive ion channel, TRPV1, which is a newly-discovered component of signaling systems in the falling heart but it role is pivotal. Critically, our study shows, for the first time, effective reversal and remediation of this pathology with long-term administration of the drugs."
"TRPV1 is a relatively newly recognized part of the endocannabinoid system and has previously been most studied as a pain receptor", explains Dr. Alexander Stokes. "TRPV1 receptors are abundant in the heart, and our data show that if we inhibit its function with promising orally-available drugs, we can effect an exciting rescue and reversal of failing heart pathology."
In December of 2016, GB Sciences licensed patents on methods for the treatment of cardiac hypertrophy and associated pathologies through regulation of the cannabinoid receptor, TRPV1, from Dr. Stokes of Makai Biotechnology. GB remains committed to cannabis-based therapies for heart disease, as demonstrated by their filing original patent applications on the use of myrcene-based complex mixtures for heart disease in May of 2017 and another patent application on cannabinoid and terpenoid-based complex mixtures for the treatment of heart disease through manipulation of cannabis-receptors in May of 2018.
John Poss, CEO of GB Sciences says, "Heart disease is still the leading global cause of death, and cannabinoid-based therapeutics are a promising new option for its treatment. At GB Sciences, we are committed to broadening the scope of scientific research using novel applications of cannabinoid therapies and rigorously demonstrating their effectiveness."
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
#CBD #Beverage Market and the 2018 Farm Bill Speculation: American Premium Water (OTC: $HIPH), Kona Gold Solutions (OTC: $KGKG), New Age Beverage ( $NBEV), Canopy Growth (TSX: $WEED.TO) (NYSE: $CGC)
Point Roberts, WA and Delta, BC - November 27, 2018 (Investorideas.com Newswire) Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the growing global opportunity for CBD beverages, with a focus on the US market and its potential explosive growth amid the much speculated and talked about passing of the 2018 Farm Bill.
The Hemp Farming Act of 2018 which will remove hemp as a designated controlled substance, legalizing the crop under federal law, will allow CBD to be legally sold in all 50 states. The main benefit seen from this change will be the increased opportunity for investment, providing the hemp industry with access to a full range of financial, market development and advisory services that were previously unavailable because of its classification as a controlled substance.
Looking at its current market position in CBD beverages and the potential moving forward if the Farm Bill passes, American Premium Water Corporation (OTC:HIPH) announced yesterday that "its LALPINA CBD beverage will be sold with Fit Food Fresh (https://www.fitfoodfresh.com) in southern Florida along with its fresh prepared food plans. Fit Food Fresh which is the highest rated food delivery program in South Florida, services customers Palm Beach, Dade, Broward and Martin counties, which according the latest census figures, comprises 6,318,747 residents, the largest population concentration in Florida."
Fishoff continued saying, "It has been a busy week since I got back from the MJBIZ conference. The partnership with Fit Food Fresh is the second significant distribution deal that the Company has closed in as many weeks." (The Company announced on November 14th it will be featured in New York City's first ever CBD pop-up shop).
New Age Beverages Corporation (NASDAQ: NBEV), announced in October that the results of its CBD-infused portfolio during the North American Convenience Store show at the Las Vegas Convention Center, October 7-10, 2018.
"New Age was the 2nd most visited and searched booth out of 1,259 exhibitors at the show and ranked in the 100th percentile in terms of booth popularity, despite debuting their new CBD-Infused products offsite at the hotel connected to the convention center. At NACS, New Age displayed their full portfolio of one-stop-shop healthy beverages and unveiled their "Live Healthy" campaign at the same time to unprecedented response and outranking some of the major other food and beverage companies at the show including Coca-Cola, Red-Bull, Monster, AB InBev, Campbells, and more than 1,000 others."
Investor Ideas discussed the importance of branding with Ryan Fishoff of American Premium Water Corporation (OTC:HIPH) at the MJBiz Conference, where he mentioned what differentiates Lalpina, the Company's premium CBD beverage lifestyle brand, with over a million Instagram (instagram.com/lalpinabrands) followers. "I dare for you to find another CBD cannabis lifestyle brand with anything close to that following. We know how to market and we have partners that know how to market."
Their marketing and branding competitive edge, in addition to their acquisition strategy resulted in an analyst upgrade, with a target Price of $0.30 in mid- October. SeeThruEquity said, "We see HIPH as an intriguing speculative growth company targeting large consumer opportunities in the CBD, blockchain and lifestyle consumer goods markets."
Listen to the podcast:CEO of American Premium Water Corporation (OTC: $HIPH) at Podcast Row, #MJBizCon
Another competitor in the CBD space and betting on its long term growth, Kona Gold Solutions, Inc. (OTC: KGKG), a hemp and CBD lifestyle brand focused on product development in the functional beverage sector, recently discussed the company's two hundred and twenty-five percent (225%) increase in revenue from the previous month on thirty-two thousand dollars ($32,000) in sales. The Company recorded its strongest month-to-date off of the signing of new distribution partners and extremely strong sales of its popular Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters. The Company has also seen an eight-seven percent (87%) increase in sales on Amazon.com over the last 30 days and a two hundred and ninety-two percent (292%) from this time last year.
The potential supply and demand increase available from the 2018 Farm Bill is not being overlooked, even Canadian based companies are examining the potential growth in the US. In a recent Motley Fool article it was reported, "Hemp production would be a natural fit for Canopy Growth (TSX:WEED) (NYSE:CGC). Constellation and Canopy have talked about launching a wide variety of cannabis-infused beverages in Canada. But if the 2018 Farm Bill becomes the law of the land, the two partners might also be able to legally launch beverages containing cannabidiol (CBD) made from hemp in the much-bigger U.S. market. Canopy Growth also wouldn't have to worry about being delisted on the Toronto Stock Exchange (TSX). The company would still be able to adhere to the TSX's listing requirements and its own commitment to only market cannabis products where they're federally legal."
With companies like these wasting no time in the interim to capitalize on branding and international opportunities in the CBD market, there is a lot at stake with the potential passing of the US Farm Bill. If it becomes law, it has the potential to alter the global beverage market as well as the landscape of the US Farm Belt.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
This news is published on the Investorideas.com Newswire - News that Inspires big ideas Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp. Disclosure: this news article featuring HIPH is a paid for news release on Investorideas.com - third party . Learn more about costs and our services https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (TSXV: $LVWL.V) (TSX: $TRST.TO) (TSX: $WEED.TO) (NYSE: $CGC) (TSXV: $N.V)
This month's cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa
Delta, Kelowna, BC - November 26, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.
Good afternoon, welcome to another Investorideas.com “potcast”, featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
Today we will be looking at announcements from LiveWell Canada Inc. (TSXV:LVWL), CannTrust Holdings Inc. (TSX: TRST), Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) and Namaste Technologies Inc. (TSXV:N) (OTCMKTS:NXTTF).
LiveWell Canada Inc. has been approved to list its common shares on the Canadian Securities Exchange (CSE). As a result, the Company will voluntarily delist its common shares from the TSXV. The transition will happen seamlessly, with LiveWell listing on the CSE starting today and the delisting from the TSXV will take place in the near future.
Moving to the CSE will allow LiveWell to accelerate its growth plans to become a global leader in the CBD market without restrictions on operating in certain international markets.
"LiveWell is preparing for its transformative progression to a global life sciences company leveraging robust CBD supply chain production capacity, while focusing on a brand development strategy that prioritizes functional products and outcomes," said David Rendimonti, President and CEO of LiveWell Canada Inc. "The CSE embraces transforming companies like LiveWell who are growing beyond the Canadian borders," he added.
Legalization and acceptance of CBD for its health and wellness benefits are accelerating at a rapid pace globally. CBD derived from hemp faces fewer legal restrictions worldwide than cannabis. The Brightfield Group of Chicago estimates the North American market alone for CBD from hemp could reach US$22 billion by 2022. While hemp cultivation, processing and sale activities are currently legal in the U.S., as per the State Farm Act, the anticipated passage of the Hemp Farming Act of 2018 would legalize hemp federally before the end of the year and essentially create the same business environment for hemp as any other agricultural commodity.
CannTrust Holdings Inc., one of Canada's leading and most trusted licensed producers of cannabis, announced today that it has shipped its standardized CBD oil capsules to Australia's Gold Coast University Hospital. The capsules will be used in a study to determine the efficacy of CannTrust CBD oil capsules in slowing the disease progression in patients with Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Disease (MND), which was first announced by the Company in July 2018. The capsules will be imported, stored and distributed by PharmaCann Pty Ltd ("PharmaCann"). The shipment will include all investigational products that are required for the study.
This study exemplifies CannTrust's focus on medical research and its dedication to uncovering the medicinal value of its proprietary cannabis products, and how they can improve health and well-being for all. In addition to assessing ALS disease progression, the study will also look at the effects of CannTrust CBD oil capsules on a variety of outcome measures related to ALS such as spasticity, pain, weight loss and quality of life. The CBD strain which will be used in the study was developed by CannTrust from its proprietary genetics, meaning that the research results will be specific to the Company's CBD oil.
Canopy Growth Corporation has closed the previously announced acquisition of the assets of ebbu, Inc. ("ebbu"), a leader in hemp research and innovation.
Intellectual Property ("IP") and R&D advancements achieved by ebbu's team apply directly to Canopy Growth's hemp and THC-rich cannabis genetic breeding program and its cannabis-infused beverage capabilities. In addition, ebbu's IP portfolio will contribute to the clinical formulations program executed by Canopy Health Innovations, a wholly owned subsidiary of the Company.
Canopy Growth operates a rapidly emerging, field-scale hemp operation based in Saskatchewan and by applying ebbu's IP, the Company has the potential to vastly reduce the cost of CBD production, a sought-after cannabinoid in both the wellness and medical spaces.
Staying with Canopy Growth's long-held position on business operations in the United States, this transaction would not have been finalized were it not in clear accordance with US federal law, along with the requisite exchange consent by the TSX. Canopy Growth, through a newly formed subsidiary, will employ ebbu's assets and personnel to conduct R&D. There will be no production or sale of products resulting from such R&D in the United States unless and until it would be federally legal to do so.
Namaste Technologies Inc. announced that the Company has signed a Subscription Agreement, whereby the Company has completed an investment of $250,000 to acquire 46,729 Class B common shares of Kief Cannabis Company Ltd. at a cost of $5.35 per share. Namaste's investment represents approximately 3% of the issued and outstanding shares of Kief Cannabis, based on an $8.1 million valuation.
Further to the Company's August 29, 2018 news release where Namaste's wholly-owned subsidiary, Cannmart Inc. signed a medical cannabis Supply Agreement to purchase premium medical cannabis products from Kief Cannabis for sale on its online platform, Cannmart will now also have the right of first refusal ("ROFR") on 35% of the total production of cannabis from Kief Cannabis.
This investment and additional security of supply bolsters Namaste's objective to become Canada's premier online medical cannabis retailer. In September, the Company received its ACMPR Sale for Medical Purposes licence, the first of its kind to be issued by Health Canada, allowing Canadian customers the ability to purchase medical cannabis from wide assortment of licensed producers through Namaste's platform, giving consumers the power of choice rather than having to register with just one LP.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
